You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

Article metrics

Article menu

Download PDFPDF

XML
Rheumatoid arthritis
Review
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

 

Online download statistics by month:

Online download statistics by month: June 2021 to November 2024

AbstractFullPdf
Jun 2021349329226
Jul 20211029669
Aug 2021878247
Sep 2021938873
Oct 2021938571
Nov 2021888347
Dec 2021595632
Jan 2022445428
Feb 202211512346
Mar 2022969859
Apr 2022847745
May 2022979161
Jun 2022514920
Jul 2022656525
Aug 202211010144
Sep 20221069440
Oct 202211010357
Nov 2022574823
Dec 2022554926
Jan 2023888433
Feb 20231049940
Mar 2023747337
Apr 2023564827
May 2023524536
Jun 2023736939
Jul 2023605636
Aug 2023302920
Sep 2023263029
Oct 2023645838
Nov 2023837335
Dec 2023403925
Jan 2024434219
Feb 2024282720
Mar 2024715447
Apr 2024736536
May 2024484520
Jun 2024504221
Jul 2024766922
Aug 202432267
Sep 2024575325
Oct 2024635133
Nov 2024605726
Total321230051710